ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
- 20 September 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Cell Metabolism
- Vol. 112 (12), 1825-1852
- https://doi.org/10.1161/circulationaha.105.167587
Abstract
No abstract availableKeywords
This publication has 159 references indexed in Scilit:
- How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?Journal of Cardiac Failure, 2004
- Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)American Heart Journal, 2004
- Outcomes in heart failure patients with preserved ejection fraction: Mortality, readmission, and functional declineJournal of the American College of Cardiology, 2003
- Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failureThe American Journal of Cardiology, 2000
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registryThe American Journal of Cardiology, 1996
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986